found
sensit
rapid
influenza
antigen
test
pandem
influenza
viru
low
moder
bd
directigen
ez
flu
ab
test
becton
dickinson
binaxnow
influenza
b
inver
medic
quickvu
influenza
ab
test
quidel
patient
influenzalik
ill
neg
rapid
antigen
test
result
undergo
test
use
reversetranscript
polymeras
chain
reaction
influenza
virus
caus
similar
symptom
diagnos
influenza
basi
clinic
present
alon
difficult
report
sensit
rang
rapid
influenza
antigen
test
pointofcar
test
might
prove
use
fast
turnaround
time
min
requir
minim
train
perform
howev
data
diagnost
accuraci
rapid
influenza
antigen
test
pandem
influenza
viru
soon
onset
pandem
influenza
outbreak
receiv
report
poor
perform
rapid
influenza
antigen
test
report
find
clinic
accuraci
commonli
use
rapid
influenza
test
diagnosi
pandem
influenza
method
period
may
june
conveni
sampl
posit
nondupl
nasopharyng
specimen
test
use
differ
rapid
antigen
test
kit
bd
directigen
ez
flu
ab
test
becton
dickinson
binaxnow
influenza
b
inver
medic
quickvu
influenza
ab
test
quidel
test
perform
accord
manufactur
instruct
test
result
interpret
least
studi
author
nasopharyng
specimen
collect
patient
present
influenzalik
ill
use
steril
polyest
nasopharyng
swab
transport
microbiolog
laboratori
viral
transport
medium
remel
specimen
posit
respiratori
virus
use
luminex
xtag
rvp
luminex
includ
luminex
xtag
rvp
multiplex
rtpcr
assay
allow
simultan
detect
respiratori
viru
typessubtyp
includ
metapneumoviru
coronavirus
influenza
viru
subtyp
influenza
b
viru
parainfluenza
viru
type
respiratori
syncyti
viru
adenoviru
rhinoviru
specimen
refriger
rapid
antigen
test
perform
h
specimen
receipt
specimen
includ
nasopharyng
sampl
posit
pandem
influenza
viru
result
confirm
use
cdc
rtpcr
assay
pandem
influenza
viru
control
specimen
includ
nasopharyng
specimen
posit
respiratori
virus
follow
adenoviru
coron
p
naviru
concurr
coronaviru
rhinoviru
n
p
n
p
metapneumoviru
rhinoviru
concurr
n
p
n
p
rhinoviru
parainfluenza
viru
parainfluenza
viru
n
p
respiratori
syncyti
viru
n
p
n
p
calcul
sensit
specif
rapid
antigen
test
determin
preval
pandem
influenza
studi
period
use
calcul
posit
predict
valu
ppv
neg
predict
valu
npv
patient
chart
review
avail
potenti
factor
may
associ
rapid
antigen
test
result
includ
patient
age
durat
symptom
present
inpati
emerg
depart
versu
outpati
statu
median
number
rtpcr
fluoresc
intens
mfi
unit
data
analysi
perform
use
spss
version
spss
mannwhitney
u
test
use
comparison
continu
variabl
x
mcnemar
test
use
categor
independ
pair
variabl
respect
p
valu
consid
statist
signific
studi
approv
institut
review
board
rush
univers
medic
center
chicago
il
result
major
patient
pandem
influenza
children
young
adult
median
age
year
rang
month
year
total
patient
assess
emerg
depart
patient
seen
physician
offic
twentytwo
patient
evalu
emerg
depart
subsequ
hospit
inform
durat
ill
present
avail
patient
major
patient
present
day
develop
symptom
influenzalik
ill
mean
interv
day
rang
day
control
patient
median
age
year
rang
month
year
control
patient
present
emerg
depart
outpati
analyt
perform
rapid
antigen
test
compar
luminex
xtag
rvp
present
tabl
overal
respect
sensit
specif
bd
directigen
ez
flu
ab
test
specimen
binaxnow
influenza
b
test
specimen
quickvu
influenza
ab
test
specimen
quickvu
influenza
ab
test
significantli
sensit
binaxnow
influenza
b
test
sigp
nific
differ
rapid
antigen
test
studi
period
overal
preval
pandem
viru
confid
interv
among
specimen
submit
respiratori
viru
rtpcr
test
basi
preval
calcul
ppv
test
calcul
npv
bd
directigen
ez
flu
ab
test
binaxnow
influenza
b
quickvu
influenza
ab
test
respect
patient
age
durat
symptom
prior
collect
respiratori
specimen
correl
significantli
result
rapid
antigen
test
higher
mfi
unit
rtpcr
p
correl
higher
viral
load
significantli
associ
posit
result
rapid
antigen
test
tabl
p
discuss
rapid
antigen
test
commonli
use
mani
hospit
laboratori
emerg
depart
doctor
offic
influenza
rapid
antigen
test
later
flow
chromatograph
immunoassay
patient
sampl
appli
chromatograph
strip
contain
monoclon
antibodi
influenza
b
virus
onsit
diagnosi
influenza
pointofcar
test
shown
limit
antibiot
prescript
use
blood
cultur
chest
radiographi
ultim
reduc
patient
cost
howev
rapid
antigen
test
demonstr
wide
rang
sensit
detect
season
influenza
virus
rang
bd
directigen
ez
flu
ab
test
binaxnow
influenza
b
test
quickvu
influenza
ab
test
found
rapid
antigen
test
low
modest
sensit
diagnosi
pandem
influenza
although
test
demonstr
excel
specif
crossreact
cocircul
respiratori
virus
possibl
reason
low
sensit
studi
includ
fact
sampl
collect
techniqu
standard
specimen
refriger
test
complet
rtpcr
may
led
antigen
degrad
howev
think
unlik
find
consist
similar
studi
ginocchio
et
al
rapid
antigen
test
sensit
pandem
influenza
viru
compar
luminex
xtag
rvp
altern
explan
may
relat
differ
test
sensit
detect
pandem
influenza
viru
compar
season
influenza
virus
studi
use
titer
pandem
influenza
viru
grown
cell
cultur
rapid
antigen
test
requir
higher
viral
load
human
season
viru
posit
result
limit
studi
includ
fact
employ
known
conveni
sampl
posit
specimen
widespread
interest
regard
clinic
perform
rapid
antigen
test
detect
pandem
influenza
viru
use
conveni
sampl
posit
specimen
allow
quick
yet
rel
accur
assess
test
addit
specimen
decod
investig
perform
test
blind
rtpcr
result
final
design
studi
permit
accur
determin
npv
ppv
calcul
valu
basi
preval
novel
influenza
studi
period
valu
would
clearli
vari
accord
preval
diseas
ppv
would
highest
peak
outbreak
increas
number
falseposit
result
diseas
preval
low
tabl
despit
modest
sensit
rapid
influenza
antigen
test
could
prove
use
test
speed
portabl
eas
perform
clinician
awar
patient
present
influenzalik
ill
neg
rapid
antigen
test
result
undergo
laboratori
test
howev
posit
rapid
antigen
test
result
would
allow
presumpt
diagnosi
novel
influenza
viru
infect
lead
time
institut
infect
control
measur
treatment
prophylaxi
final
approach
winter
season
desir
manufactur
develop
sensit
rapid
antigen
kit
also
differenti
season
influenza
virus
pandem
influenza
viru
view
differ
antivir
suscept
